A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Viridian Therapeutics Inc’s current trading price is -14.86% away from its 52-week high, while its distance from the 52-week low is 103.15%. The stock’s price range for this time frame has been between $11.40 and $27.20. The trading volume of the company’s shares in the Healthcare reached around 4.71 million for the day, which was evidently higher than the average daily volume of 1.12 million over the last three months.
Viridian Therapeutics Inc’s stock has had a calm market performance. The 1-year high for the company’s stock was $27.20 on 11/12/24, and the lowest price during the same period was recorded at $11.40 on 06/04/24.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
How Financial Performance Impacts Market Capitalization
Viridian Therapeutics Inc (VRDN) has experienced a quarterly rise of 9.34% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.82B and boasts a workforce of 96 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 19.94, with a change in price of +7.00. Similarly, Viridian Therapeutics Inc recorded 1,347,707 in trading volume during the last 100 days, posting a change of +42.81%.
How VRDN’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for VRDN stands at 0.03. Similarly, the long-term debt-to-equity ratio is also 0.03.
VRDN Stock Stochastic Average
The raw stochastic average for Viridian Therapeutics Inc over the last 50 days is presently at 61.16%. This reflects a drop from the raw stochastic average of the previous 20 days, which was noted at 100.00%. Further, the company’s Stochastic %K and %D values for the last 20 days were 37.53% and 14.55%, respectively.
VRDN Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. This year’s metric has recorded a Price increase of 6.33%. However, over the past six months, we’ve seen a weaker performance of 89.83%. The price of VRDN fallen by 7.02% over the last 30 days. And in the last five days, it has surged by 18.58%.
